Vimarsana
Biggest News Aggregation in the World

Page 2 - Virtual Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virtual Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virtual Biotech Today - Breaking & Trending Today

Trial offers hope of a breakthrough in treatment for Parkinson's disease - Vimarsana News

Trial offers hope of a breakthrough in treatment for Parkinson's disease

The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.

Parkinson's Foundation Launches #Take6forPD Campaign for Parkinson's Awareness Month - Vimarsana News

Parkinson's Foundation Launches #Take6forPD Campaign for Parkinson's Awareness Month

/PRNewswire/ -- The Parkinson's Foundation brings Parkinson's disease (PD) to the forefront with the launch of a new awareness campaign, #Take6forPD. April is...

NRG Therapeutics Ltd: NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson's and ALS - Vimarsana News

NRG Therapeutics Ltd: NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson's and ALS

£16 million Series A led by Omega Funds, to advance disease-modifying oral medicines for debilitating chronic neurodegenerative disorders through IND-enabling studiesDeveloping a pipeline of

Brandon Capital Invests in Neuroscience Company NRG Therapeutics - Vimarsana News

Brandon Capital Invests in Neuroscience Company NRG Therapeutics

Brandon Capital, Australasia’s leading life science venture capital firm, is pleased to announce its investment into neuroscience company NRG Therapeutics as part of its £16m (AUD$29m) series A financing. Brandon Capital participated alongside Omega Funds, which led the round, as well as NRG’s founding investor ...

NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson's and ALS - Vimarsana News

NRG Therapeutics Announces £16 million Series A to Advance Mitochondrial Therapeutics for Parkinson's and ALS

£16 million Series A led by Omega Funds, to advance disease-modifying oral medicines for debilitating chronic neurodegenerative disorders through IND-enabling...